RPS15mutations and Treatment Outcome in Chronic Lymphocytic Leukemia - Results from the CLL11 Phase III Trial (Chlorambucil (Clb) with or without the Addition of Rituximab (R) or Obinutuzumab (GA101, G)) of the German CLL Study Group
In: Blood, Jg. 130 (2017-12-08), Heft 1, Number 1 Supplement 1, S. 1738-1738
Online
serialPeriodical
Zugriff:
BACKGROUND
Titel: |
RPS15mutations and Treatment Outcome in Chronic Lymphocytic Leukemia - Results from the CLL11 Phase III Trial (Chlorambucil (Clb) with or without the Addition of Rituximab (R) or Obinutuzumab (GA101, G)) of the German CLL Study Group
|
---|---|
Autor/in / Beteiligte Person: | Estenfelder, Sven ; Holland-Letz, Ann-Kathrin ; Tausch, Eugen ; Robrecht, Sandra ; Bahlo, Jasmin ; Goede, Valentin ; Opatrna, Veronika ; Ritgen, Matthias ; van Dongen, Jacques JM ; Langerak, Anton W ; Fingerle-Rowson, Günter ; Kneba, Michael ; Fischer, Kirsten ; Hallek, Michael ; Döhner, Hartmut ; Stilgenbauer, Stephan |
Link: | |
Zeitschrift: | Blood, Jg. 130 (2017-12-08), Heft 1, Number 1 Supplement 1, S. 1738-1738 |
Veröffentlichung: | 2017 |
Medientyp: | serialPeriodical |
ISSN: | 0006-4971 (print) ; 1528-0020 (print) |
DOI: | 10.1182/blood.V130.Suppl_1.1738.1738 |
Sonstiges: |
|